Benjamin Philpot
Professor of neuroscience
University of North Carolina at Chapel Hill
From this contributor
Angelman syndrome: Bellwether for genetic therapy in autism
It is not a matter of whether there will be clinical trials of genetic therapy for Angelman syndrome, but when.
Angelman syndrome: Bellwether for genetic therapy in autism
Insights for autism from Angelman syndrome
Deletions or duplications of the UBE3A gene lead to both Angelman syndrome and some cases of autism, respectively. Studying the effects of altered gene dosage in this region will provide insights into brain defects and suggest targets for therapies for both disorders, says expert Benjamin Philpot.
Insights for autism from Angelman syndrome
Explore more from The Transmitter
Perspectives from the field: Opinions in autism research
This collection of Spectrum articles from the past 12 months highlights expert perspectives on autism’s heritability and its link to biological sex, the value of transdiagnostic frameworks, and the field’s future, among other topics.
Perspectives from the field: Opinions in autism research
This collection of Spectrum articles from the past 12 months highlights expert perspectives on autism’s heritability and its link to biological sex, the value of transdiagnostic frameworks, and the field’s future, among other topics.
Nature retracts paper on novel brain cell type against authors’ wishes
A 2022 paper was retracted after an independent team of researchers reanalyzed the data and questioned its validity.
Nature retracts paper on novel brain cell type against authors’ wishes
A 2022 paper was retracted after an independent team of researchers reanalyzed the data and questioned its validity.
Rise in autism prevalence but not traits; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 7 July.
Rise in autism prevalence but not traits; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 7 July.